These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 27349451)
1. Ruthenium(II) Complexes as Potential Apoptosis Inducers in Chemotherapy. Zheng K; Wu Q; Wang C; Tan W; Mei W Anticancer Agents Med Chem; 2017; 17(1):29-39. PubMed ID: 27349451 [TBL] [Abstract][Full Text] [Related]
2. Ruthenium(II) complexes as apoptosis inducers by stabilizing c-myc G-quadruplex DNA. Zhang Z; Wu Q; Wu XH; Sun FY; Chen LM; Chen JC; Yang SL; Mei WJ Eur J Med Chem; 2014 Jun; 80():316-24. PubMed ID: 24793882 [TBL] [Abstract][Full Text] [Related]
3. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling. Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850 [TBL] [Abstract][Full Text] [Related]
4. Anti-tumor activity and mechanism of apoptosis of A549 induced by ruthenium complex. Sun D; Mou Z; Li N; Zhang W; Wang Y; Yang E; Wang W J Biol Inorg Chem; 2016 Dec; 21(8):945-956. PubMed ID: 27620172 [TBL] [Abstract][Full Text] [Related]
5. Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands. Biersack B Mini Rev Med Chem; 2016; 16(10):804-14. PubMed ID: 27161009 [TBL] [Abstract][Full Text] [Related]
6. Arene ruthenium(II) Complexes: The Promising Chemotherapeutic Agent in Inhibiting the Proliferation, Migration and Invasion. Zheng K; Wu Q; Ding Y; Mei W Mini Rev Med Chem; 2016; 16(10):796-803. PubMed ID: 26423698 [TBL] [Abstract][Full Text] [Related]
7. Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy. Abid M; Shamsi F; Azam A Mini Rev Med Chem; 2016; 16(10):772-86. PubMed ID: 26423699 [TBL] [Abstract][Full Text] [Related]
8. Interaction between 8-hydroxyquinoline ruthenium(II) complexes and basic fibroblast growth factors (bFGF): inhibiting angiogenesis and tumor growth through ERK and AKT signaling pathways. Yang L; Zhang J; Wang C; Qin X; Yu Q; Zhou Y; Liu J Metallomics; 2014 Mar; 6(3):518-31. PubMed ID: 24336978 [TBL] [Abstract][Full Text] [Related]
9. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes. Ma W; Zhang S; Tian Z; Xu Z; Zhang Y; Xia X; Chen X; Liu Z Eur J Med Chem; 2019 Nov; 181():111599. PubMed ID: 31408807 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells. Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015 [TBL] [Abstract][Full Text] [Related]
11. Ruthenium complexes with phenylterpyridine derivatives target cell membrane and trigger death receptors-mediated apoptosis in cancer cells. Deng Z; Gao P; Yu L; Ma B; You Y; Chan L; Mei C; Chen T Biomaterials; 2017 Jun; 129():111-126. PubMed ID: 28340357 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia-Sensitive Metal β-Ketoiminato Complexes Showing Induced Single-Strand DNA Breaks and Cancer Cell Death by Apoptosis. Lord RM; Hebden AJ; Pask CM; Henderson IR; Allison SJ; Shepherd SL; Phillips RM; McGowan PC J Med Chem; 2015 Jun; 58(12):4940-53. PubMed ID: 25906293 [TBL] [Abstract][Full Text] [Related]
13. Protein-binding, cytotoxicity in vitro and cell cycle arrest of ruthenium(II) polypyridyl complexes. Liu SH; Zhu JW; Xu HH; Wang Y; Liu YM; Liang JB; Zhang GQ; Cao DH; Lin YY; Wu Y; Guo QF Spectrochim Acta A Mol Biomol Spectrosc; 2016 May; 161():77-82. PubMed ID: 26956530 [TBL] [Abstract][Full Text] [Related]
14. Dinuclear Organoruthenium Complexes Exhibiting Antiproliferative Activity through DNA Damage and a Reactive-Oxygen-Species-Mediated Endoplasmic Reticulum Stress Pathway. Zhao J; Li S; Wang X; Xu G; Gou S Inorg Chem; 2019 Feb; 58(3):2208-2217. PubMed ID: 30675781 [TBL] [Abstract][Full Text] [Related]
15. A ruthenium(II) complex capable of inducing and stabilizing bcl-2 G-quadruplex formation as a potential cancer inhibitor. Zhang J; Yu Q; Li Q; Yang L; Chen L; Zhou Y; Liu J J Inorg Biochem; 2014 May; 134():1-11. PubMed ID: 24513610 [TBL] [Abstract][Full Text] [Related]
16. Development of Arene Ruthenium Antitumor Complexes. Su W; Tang Z; Li P Mini Rev Med Chem; 2016; 16(10):787-95. PubMed ID: 27161008 [TBL] [Abstract][Full Text] [Related]
17. Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)] Purushothaman B; Arumugam P; Ju H; Kulsi G; Samson AAS; Song JM Eur J Med Chem; 2018 Aug; 156():747-759. PubMed ID: 30048924 [TBL] [Abstract][Full Text] [Related]
18. Editorial: Anticancer Ruthenium Complexes in Drug Discovery and Medicinal Chemistry. Thota S Mini Rev Med Chem; 2016; 16(10):771. PubMed ID: 27161007 [No Abstract] [Full Text] [Related]
19. Water-Soluble Ruthenium(II) Complexes with Chiral 4-(2,3-Dihydroxypropyl)-formamide Oxoaporphine (FOA): In Vitro and in Vivo Anticancer Activity by Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Induction of Tumor Cell Apoptosis. Chen ZF; Qin QP; Qin JL; Zhou J; Li YL; Li N; Liu YC; Liang H J Med Chem; 2015 Jun; 58(11):4771-89. PubMed ID: 25988535 [TBL] [Abstract][Full Text] [Related]
20. A novel ruthenium(II)-polypyridyl complex inhibits cell proliferation and induces cell apoptosis by impairing DNA damage repair. Yang Q; Zhang Z; Mei W; Sun F J Chemother; 2014 Aug; 26(4):235-42. PubMed ID: 24070188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]